Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study
Texas Liver Institute · The University of Texas Health Science Center at San Antonio · +17 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
817
total citations
- FWCI
- 83.86
- Percentile
- 100%
- References
- 17
Citations per year
Authors
22Topics & keywords
Topics
Keywords
- Simeprevir
- Ribavirin
- Medicine
- Sofosbuvir
- Internal medicine
- Cohort
- Pegylated interferon
- Adverse effect
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.